title: Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels.
authors.affiliation: Nephrology Department, University Medical Center Nijmegen, PO Box 9101, 6500 HB Nijmegen, the Netherlands.
authors.forename: M A
authors.initials: MA
authors.lastname: Artz
authors.forename: J M M
authors.initials: JM
authors.lastname: Boots
authors.forename: G
authors.initials: G
authors.lastname: Ligtenberg
authors.forename: J I
authors.initials: JI
authors.lastname: Roodnat
authors.forename: M H L
authors.initials: MH
authors.lastname: Christiaans
authors.forename: R J
authors.initials: RJ
authors.lastname: Hené
authors.forename: H J
authors.initials: HJ
authors.lastname: Blom
authors.forename: P N M
authors.initials: PN
authors.lastname: Demacker
authors.forename: L B
authors.initials: LB
authors.lastname: Hilbrands
mesh_terms: D016572:Cyclosporine / Q000009:adverse effects*; D005500:Follow-Up Studies; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D008055:Lipids; D008074:Lipoproteins; D006710:Homocysteine; D016572:Cyclosporine; D016559:Tacrolimus